World's Best Scientists 2026 revealed!
Ansgar W. Lohse

Ansgar W. Lohse

D-Index & Metrics

Medicine

D-Index
103
Citations
34953
World Ranking
7422
National Ranking
423

Overview

Ansgar W. Lohse is affiliated with Universität Hamburg in Germany. Their research primarily focuses on medicine, with a specialization in hepatology. The subfields of study in which they are active include hepatology, epidemiology, infectious diseases, surgery, and immunology.

The main topics of research covered by Lohse include:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatitis B Virus Studies
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis C virus research

Their frequent co-authors include:

  • Christoph Schramm
  • Samuel Huber
  • Marcial Sebode
  • Julian Schulze zur Wiesch
  • Marylyn M. Addo

Common publication venues for Lohse's work are:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • Liver International
  • JHEP Reports
  • bioRxiv (Cold Spring Harbor Laboratory)

Recent papers published by Lohse include:

  • FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2, 2022, Nature
  • A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease, 2021, New England Journal of Medicine
  • Diagnosis and management of autoimmune hepatitis, 2023, BMJ
  • Clonal expansion and activation of tissue-resident memory-like T H 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19, 2021, Science Immunology
  • Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial, 2020, The Lancet Infectious Diseases

Best Publications

  • Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

    Kirsten Muri Boberg;Roger W Chapman;Gideon M Hirschfield;Ansgar W Lohse

  • Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

    Gerd Otto;Sascha Herber;Michael Heise;Ansgar W. Lohse

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

    Michael P. Manns;Marek Woynarowski;Wolfgang Kreisel;Yoav Lurie

  • Immune tolerance: what is unique about the liver.

    Gisa Tiegs;Ansgar W. Lohse

  • Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

    Ingrid Wies;Silvia Brunner;Juergen Henninger;Johannes Herkel

  • Autoimmune hepatitis – Update 2015

    Michael P. Manns;Ansgar W. Lohse;Diego Vergani

  • Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells.

    Percy A. Knolle;Edgar Schmitt;Shenciu Jin;Tieno Germann

  • A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia

    Benno Kreuels;Dominic Wichmann;Petra Emmerich;Jonas Schmidt-Chanasit

  • The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus

    Tassilo Volz;Lena Allweiss;Mounira Ben MBarek;Michael Warlich

  • Primary sclerosing cholangitis

    Jessica K Dyson;Ulrich Beuers;David E J Jones;Ansgar W Lohse

  • Genome-wide association study identifies variants associated with autoimmune hepatitis type 1

    Ynto S. de Boer;Nicole M.F. van Gerven;Antonie Zwiers;Bart J. Verwer

  • TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis

    Stephan Kanzler;Stephan Kanzler;Ansgar W. Lohse;Andrea Keil;Jürgen Henninger;Jürgen Henninger

  • Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice

    Piotr Czochra;Borut Klopcic;Erik Meyer;Johannes Herkel

  • Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells.

    AW Lohse;PA Knolle;K Bilo;A Uhrig

  • Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.

    Kornelius Schulze;Christin Gasch;Katharina Staufer;Björn Nashan

  • Pregnancy in autoimmune hepatitis: outcome and risk factors.

    Christoph Schramm;Johannes Herkel;Ulrich Beuers;Stephan Kanzler

  • Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

    Christina Weiler-Normann;Christoph Schramm;Alexander Quaas;Christiane Wiegard

  • Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.

    Stefan Wirtz;Susetta Finotto;Stephan Kanzler;Ansgar W. Lohse

  • BASIC AND TRANSLATIONAL—LIVER Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

    Ynto S. de Boer;Nicole M. F. van Gerven;Antonie Zwiers;Bart J. Verwer

Frequent Co-Authors

Peter R. Galle
Peter R. Galle Johannes Gutenberg University of Mainz
Marc Lütgehetmann
Marc Lütgehetmann University Medical Center Hamburg-Eppendorf
Markus F. Neurath
Markus F. Neurath University of Erlangen-Nuremberg
Marylyn M. Addo
Marylyn M. Addo Universität Hamburg
Maura Dandri
Maura Dandri Universität Hamburg
Michael P. Manns
Michael P. Manns Hannover Medical School
Bernd Löwe
Bernd Löwe Universität Hamburg
Nicola Gagliani
Nicola Gagliani Universität Hamburg
Irun R. Cohen
Irun R. Cohen Weizmann Institute of Science
Marcus Altfeld
Marcus Altfeld University Medical Center Hamburg-Eppendorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The path to a medical career in the USA isn’t limited to the traditional MD. Numerous online degrees make healthcare more accessible while offering varied career opportunities. Online LPN programs are perfect for those eager to enter the workforce quickly and begin making a difference as Licensed Practical Nurses. These programs typically offer flexible study schedules, ideal for balancing other commitments.

For registered nurses seeking specialization, fast track mental health nursing degrees can provide a pathway to become Psychiatric-Mental Health Nurse Practitioners. These fast-track programs help meet the growing demand for mental health professionals while letting students accelerate their careers.

Outside of direct patient care, there are rewarding roles in health management. Pursuing a health administration degree online equips students with essential management skills for healthcare settings. For those interested in further advancing, there are online MHA programs affordable enough to help working professionals earn master’s degrees without incurring overwhelming debt.

These online options create flexible, affordable paths to impactful healthcare careers beyond traditional medicine study.

Best Scientists Citing Ansgar W. Lohse

Trending Scientists